Center for Bioethics Papers

Document Type

Journal Article

Date of this Version

April 2003


On September 4, 2001, press reports indicated that the Defense Intelligence Agency of the U.S. Department of Defense (DOD) planned to reproduce a strain of anthrax virus suspected of being held in Russian laboratories. According to the same reports, the Central Intelligence Agency (CIA), under the auspices of Project Clear Vision, is engaged in building replicas of bomblets believed to have been developed by the former Soviet Union. These small bombs were designed to disperse biological agents, including anthrax. Government attorneys were said to be confident that, because these projects were designed to develop defensive measures, they were not in violation of the 1972 Biological and Toxin Weapons Convention.


© Cambridge University Press 2003.
Reprinted from Cambridge Quarterly of Healthcare Ethics, Volume 12, Issue 2, April 2003, pages 192-195.
Publisher URL:

NOTE: At the time of publication, the author was affiliated with the University of Virginia. Currently May 2007, he is a faculty member in the Department of Bioethics at the School of Medicine of the University of Pennsylvania.



Date Posted: 29 May 2007

This document has been peer reviewed.